Polar Asset Management Partners Inc. Trims Stock Position in Kenvue Inc. $KVUE

Polar Asset Management Partners Inc. lessened its stake in Kenvue Inc. (NYSE:KVUE) by 44.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 94,334 shares of the company’s stock after selling 74,905 shares during the period. Polar Asset Management Partners Inc.’s holdings in Kenvue were worth $1,626,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Arrowstreet Capital Limited Partnership acquired a new position in Kenvue in the second quarter valued at approximately $6,528,000. Jump Financial LLC grew its stake in shares of Kenvue by 210.6% during the 2nd quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock worth $1,147,000 after purchasing an additional 37,170 shares during the period. AXA S.A. increased its holdings in shares of Kenvue by 21.1% during the 2nd quarter. AXA S.A. now owns 48,892 shares of the company’s stock valued at $1,023,000 after purchasing an additional 8,524 shares in the last quarter. NewEdge Advisors LLC increased its holdings in shares of Kenvue by 219.1% during the 2nd quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after purchasing an additional 66,930 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of Kenvue by 0.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after purchasing an additional 10,885 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.59% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

KVUE has been the topic of a number of recent analyst reports. UBS Group increased their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, July 16th. Citigroup cut their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a research report on Sunday, July 12th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Finally, Barclays raised their target price on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $19.58.

Kenvue Price Performance

NYSE:KVUE opened at $19.43 on Tuesday. The stock has a 50 day moving average of $18.42 and a two-hundred day moving average of $17.94. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $22.74. The firm has a market cap of $37.32 billion, a P/E ratio of 22.86, a price-to-earnings-growth ratio of 1.46 and a beta of 0.47. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same period in the previous year, the company posted $0.24 earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. On average, analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.3%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s payout ratio is 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.